Compositions and uses thereof for the treatment of chronic feline respiratory disorders

Abstract

The present invention relates to compositions useful in the field of veterinary medicine and more particularly compositions comprising pheromones for treating feline chronic respiratory disorders and complications thereof and/or feline chronic infectious disorders or conditions.

1 - 15 . (canceled) 
     
     
         16 . A method for treating feline chronic respiratory disorders or complications thereof and/or feline chronic infectious disorders or complications comprising administering to a feline in need thereof a veterinary composition comprising pheromones. 
     
     
         17 . The method according to  claim 16 , wherein the feline has a feline chronic respiratory disorders. 
     
     
         18 . The method according to  claim 16 , wherein the feline chronic infectious disorders or feline chronic respiratory disorders are due to infections. 
     
     
         19 . The method according to  claim 16 , wherein the feline chronic respiratory disorders is caused by a herpes infection or a FHV-1 infection. 
     
     
         20 . The method according to  claim 16 , wherein the feline chronic respiratory tract disorder is a chronic upper respiratory tract disorders. 
     
     
         21 . The method according to  claim 20 , wherein the treatment lessens or reduces sneezing. 
     
     
         22 . The method according to  claim 16 , wherein said treatment increases relaxation as evidenced by increased sleep period of felines with infectious disorders and/or respiratory disorders. 
     
     
         23 . The method according to  claim 18 , said method reducing clinical symptoms due to feline chronic infections. 
     
     
         24 . The method according to  claim 23 , wherein said clinical symptoms due to feline chronic infections are cough, sneezing, nasal discharge, nasal congestion, ocular discharge, ocular congestion, and/or blepharospasm. 
     
     
         25 . The method according to  claim 17 , said method reducing clinical symptoms due to feline chronic respiratory disorders. 
     
     
         26 . The method according to  claim 25 , wherein said clinical symptoms due to feline chronic respiratory disorders due to infections are cough, sneezing, nasal discharge, and/or nasal congestion. 
     
     
         27 . The method according to  claim 16 , wherein the veterinary composition comprises a mixture of oleic acid, azelaic acid, pimelic acid and palmitic acid, or derivatives thereof. 
     
     
         28 . The method according to  claim 16 , wherein the composition comprises at least a therapeutically effective amount of active fatty acids or ester or methyl ester derivatives thereof, said fatty acids being selected from the group consisting of oleic acid, azelaic acid, pimelic acid and palmitic acid. 
     
     
         29 . The method according to  claim 16 , wherein the composition comprises a mixture of fatty acids comprising at least about 45-60% oleic acid, 6-10% of azelaic acid, 8-12% of pimelic acid, and 13-18% of palmitic acid, with respect to the total weight of fatty acids and derivatives thereof, or a mixture comprising between about 45-65% methyl oleate, between about 6-10% dimethyl azelate, between about 8-12% of dimethyl pimelate, and between about 13-18% of methyl palmitate, with respect to the total weight of fatty acids and derivatives thereof, or a mixture of esters of fatty acids comprising approximately 47-51% of methyl oleate, approximately 7-9% of azelate of dimethyl, between 9-11% of dimethyl pimelate and approximately 14-16% of methyl palmitate, with respect to the total weight of fatty acids and derivatives thereof.